{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:15:24Z","timestamp":1776352524848,"version":"3.51.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Special Project of Medical Technology Discipline of Fujian University of Traditional Chinese Medicine","award":["X202306-medical technolog"],"award-info":[{"award-number":["X202306-medical technolog"]}]},{"name":"Fujian Province and the Nature Science Funding of Fujian Provinc","award":["2025J01795"],"award-info":[{"award-number":["2025J01795"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10096-025-05394-0","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:14:42Z","timestamp":1767680082000},"page":"1069-1076","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for antibiotic resistance and 30-day mortality among adult patients with acute leukemia and Escherichia coli bloodstream infection"],"prefix":"10.1007","volume":"45","author":[{"given":"Juan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaili","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxian","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munire","family":"Abudumaijiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jilai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiadi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinmiao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"5394_CR1","doi-asserted-by":"publisher","unstructured":"Wang J, Mu M, Zhu J et al. Adult acute leukemia patients with gram-negative bacteria bloodstream infection: risk factors and outcomes of antibiotic-resistant bacteria. Ann Hematol 103(10):4021\u20134031. https:\/\/doi.org\/10.1007\/s00277-024-05866-x","DOI":"10.1007\/s00277-024-05866-x"},{"issue":"Suppl 4","key":"5394_CR2","doi-asserted-by":"publisher","first-page":"S386","DOI":"10.1093\/cid\/ciaa1522","volume":"71","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Lin Q, Liu L et al (2020) Risk factors and outcomes of Antibiotic-resistant Pseudomonas aeruginosa bloodstream infection in adult patients with acute leukemia. Clin Infect Dis 71(Suppl 4):S386\u2013S393. https:\/\/doi.org\/10.1093\/cid\/ciaa1522","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5394_CR3","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jiac.2023.01.004","volume":"29","author":"N Yoshino","year":"2023","unstructured":"Yoshino N, Kimura SI, Matsuoka A et al (2023) Clinical features of febrile neutropenia and bloodstream infection in autologous hematopoietic cell transplantation: comparison to those in intensive chemotherapy for acute myeloid leukemia. J Infect Chemother 29(4):384\u2013390. https:\/\/doi.org\/10.1016\/j.jiac.2023.01.004","journal-title":"J Infect Chemother"},{"issue":"7","key":"5394_CR4","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/cid\/ciaa210","volume":"72","author":"M Bonten","year":"2021","unstructured":"Bonten M, Johnson JR, van den Biggelaar AHJ et al (2021) Epidemiology of Escherichia coli bacteremia: A systematic literature review. Clin Infect Dis 72(7):1211\u20131219. https:\/\/doi.org\/10.1093\/cid\/ciaa210","journal-title":"Clin Infect Dis"},{"issue":"3","key":"5394_CR5","doi-asserted-by":"publisher","first-page":"e0139921","DOI":"10.1128\/Spectrum.01399-21","volume":"9","author":"T Kobayashi","year":"2021","unstructured":"Kobayashi T, Ikeda M, Okada Y, Higurashi Y, Okugawa S, Moriya K (2021) Clinical and Microbiological characteristics of recurrent Escherichia coli bacteremia. Microbiol Spectr 9(3):e0139921. https:\/\/doi.org\/10.1128\/Spectrum.01399-21","journal-title":"Microbiol Spectr"},{"issue":"1","key":"5394_CR6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1186\/s12879-021-06326-x","volume":"21","author":"MC MacKinnon","year":"2021","unstructured":"MacKinnon MC, McEwen SA, Pearl DL et al (2021) Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study. BMC Infect Dis 21(1):606. https:\/\/doi.org\/10.1186\/s12879-021-06326-x","journal-title":"BMC Infect Dis"},{"issue":"9","key":"5394_CR7","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.cmi.2025.05.033","volume":"31","author":"A Gallardo-Pizarro","year":"2025","unstructured":"Gallardo-Pizarro A, Lopera C, Peyrony O et al (2025) Rectal colonization by multidrug-resistant Gram-negative bacteria and subsequent bacteraemia in haematological patients. Clin Microbiol Infect 31(9):1579\u20131583. https:\/\/doi.org\/10.1016\/j.cmi.2025.05.033","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"5394_CR8","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.pathol.2024.04.013","volume":"56","author":"F Langham","year":"2024","unstructured":"Langham F, Tsai D, Forde BM, Camilleri S, Harris PNA, Roberts JA, Chiong F (2024) Demographic, clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections in central Australia. Pathology 56(7):1012\u20131020. https:\/\/doi.org\/10.1016\/j.pathol.2024.04.013","journal-title":"Pathology"},{"issue":"43","key":"5394_CR9","doi-asserted-by":"publisher","first-page":"2200934","DOI":"10.2807\/1560-7917.ES.2023.28.43.2200934","volume":"28","author":"H Ilmavirta","year":"2023","unstructured":"Ilmavirta H, Ollgren J, R\u00e4is\u00e4nen K et al (2023) Increasing proportions of extended-spectrum \u03b2-lactamase-producing isolates among Escherichia coli from urine and bloodstream infections: results from a nationwide surveillance network, Finland, 2008 to 2019. Euro Surveill 28(43):2200934. https:\/\/doi.org\/10.2807\/1560-7917.ES.2023.28.43.2200934","journal-title":"Euro Surveill"},{"key":"5394_CR10","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.2147\/IDR.S305281","volume":"14","author":"D Li","year":"2021","unstructured":"Li D, Li P, Yu X, Zhang X, Guo Q, Xu X, Wang M, Wang M (2021) Molecular characteristics of Escherichia coli causing bloodstream infections during 2010\u20132015 in a tertiary Hospital, Shanghai, China. Infect Drug Resist 14:2079\u20132086. https:\/\/doi.org\/10.2147\/IDR.S305281","journal-title":"Infect Drug Resist"},{"issue":"1","key":"5394_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s42506-023-00134-8","volume":"98","author":"N Mohamed","year":"2023","unstructured":"Mohamed N, Ghazal A, Ahmed AAH, Zaki A (2023) Prevalence and determinants of antimicrobial resistance of pathogens isolated from cancer patients in an intensive care unit in Alexandria, Egypt. J Egypt Public Health Assoc 98(1):9. https:\/\/doi.org\/10.1186\/s42506-023-00134-8","journal-title":"J Egypt Public Health Assoc"},{"issue":"1","key":"5394_CR12","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12879-021-06243-z","volume":"21","author":"A Amanati","year":"2021","unstructured":"Amanati A, Sajedianfard S, Khajeh S, Ghasempour S, Mehrangiz S, Nematolahi S, Shahhosein Z (2021) Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance. BMC Infect Dis 21(1):636. https:\/\/doi.org\/10.1186\/s12879-021-06243-z","journal-title":"BMC Infect Dis"},{"issue":"1","key":"5394_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/23744235.2023.2261538","volume":"56","author":"N Handal","year":"2024","unstructured":"Handal N, Whitworth J, Lyngbakken MN, Berdal JE, Dalgard O, Bakken J\u00f8rgensen S (2024) Mortality and length of hospital stay after bloodstream infections caused by ESBL-producing compared to non-ESBL-producing E. coli. Infect Dis (Lond) 56(1):19\u201331. https:\/\/doi.org\/10.1080\/23744235.2023.2261538","journal-title":"Infect Dis (Lond)"},{"issue":"6","key":"5394_CR14","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/antibiotics12061003","volume":"12","author":"BJ Haimerl","year":"2023","unstructured":"Haimerl BJ, Encinas R, Justo JA, Kohn J, Bookstaver PB, Winders HR, Al-Hasan MN (2023) Optimization of empirical antimicrobial therapy in enterobacterales bloodstream infection using the Extended-Spectrum Beta-Lactamase prediction score. Antibiot (Basel) 12(6):1003. https:\/\/doi.org\/10.3390\/antibiotics12061003","journal-title":"Antibiot (Basel)"},{"issue":"5","key":"5394_CR15","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s10123-024-00481-2","volume":"27","author":"H Shao","year":"2024","unstructured":"Shao H, Zhang X, Li Y, Gao Y, Wang Y, Shao X, Dai L (2024) Epidemiology and drug resistance analysis of bloodstream infections in an intensive care unit from a children\u2019s medical center in Eastern China for six consecutive years. Int Microbiol 27(5):1345\u20131355. https:\/\/doi.org\/10.1007\/s10123-024-00481-2","journal-title":"Int Microbiol"},{"key":"5394_CR16","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.2147\/IDR.S413454","volume":"16","author":"S Wang","year":"2023","unstructured":"Wang S, Song Y, Shi N, Yin D, Kang J, Cai W, Duan J (2023) Characteristics, Outcomes, and clinical indicators of bloodstream infections in neutropenic patients with hematological malignancies: A 7-Year retrospective study. Infect Drug Resist 16:4471\u20134487. https:\/\/doi.org\/10.2147\/IDR.S413454","journal-title":"Infect Drug Resist"},{"key":"5394_CR17","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.2147\/RMHP.S535221","volume":"18","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Sun L, Li X, Zhang R, Liu J, Li J (2025) Risk factors and clinical management strategies for bloodstream infections in pediatric hematological malignancies. Risk Manag Healthc Policy 18:3303\u20133310. https:\/\/doi.org\/10.2147\/RMHP.S535221","journal-title":"Risk Manag Healthc Policy"},{"key":"5394_CR18","doi-asserted-by":"publisher","first-page":"1471477","DOI":"10.3389\/fcimb.2024.1471477","volume":"14","author":"Y Chen","year":"2024","unstructured":"Chen Y, Huang J, Dong L, Xu B, Li L, Zhao Z, Li B (2024) Clinical and genomic characterization of carbapenem-resistant enterobacterales bloodstream infections in patients with hematologic malignancies. Front Cell Infect Microbiol 14:1471477. https:\/\/doi.org\/10.3389\/fcimb.2024.1471477","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"5394_CR19","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s10096-022-04423-6","volume":"41","author":"S Zhao","year":"2022","unstructured":"Zhao S, Wu Y, Dai Z, Chen Y, Zhou X, Zhao J (2022) Risk factors for antibiotic resistance and mortality in patients with bloodstream infection of Escherichia coli. Eur J Clin Microbiol Infect Dis 41(5):713\u2013721. https:\/\/doi.org\/10.1007\/s10096-022-04423-6","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"5394_CR20","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.cmi.2021.12.009","volume":"28","author":"SF Feldman","year":"2022","unstructured":"Feldman SF, Temkin E, Wullfhart L, Nutman A, Schechner V, Shitrit P, Shvartz R, Schwaber MJ, Andremont A, Carmeli Y (2022) A nationwide population-based study of Escherichia coli bloodstream infections: incidence, antimicrobial resistance and mortality. Clin Microbiol Infect 28(6):879. https:\/\/doi.org\/10.1016\/j.cmi.2021.12.009","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"5394_CR21","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.jiph.2023.07.010","volume":"16","author":"R Merdad","year":"2023","unstructured":"Merdad R, Alyami A, Basalim A, Alzahrani A, Aldainiy A, Awadh A, Ghulam E, Farahat F (2023) Bloodstream gram-negative bacterial infections in adult patients with leukemia: A retrospective review of medical records in a tertiary care hospital in Western Saudi Arabia. J Infect Public Health 16(10):1525\u20131530. https:\/\/doi.org\/10.1016\/j.jiph.2023.07.010","journal-title":"J Infect Public Health"},{"issue":"9","key":"5394_CR22","doi-asserted-by":"publisher","first-page":"979","DOI":"10.15537\/smj.2016.9.14211","volume":"37","author":"FE Al-Otaibi","year":"2016","unstructured":"Al-Otaibi FE, Bukhari EE, Badr M, Alrabiaa AA (2016) Prevalence and risk factors of Gram-negative bacilli causing blood stream infection in patients with malignancy. Saudi Med J 37(9):979\u2013984. https:\/\/doi.org\/10.15537\/smj.2016.9.14211","journal-title":"Saudi Med J"},{"key":"5394_CR23","doi-asserted-by":"publisher","unstructured":"Zheng J, Li J, Xu X, Li Y, Yang Y, Guo Y, Hu J, Wang L (2025) Microbiology and predictors of mortality in haematological malignancy patients with gram-negative bacterial bloodstream infections. Microbes Infect 9:105563. https:\/\/doi.org\/10.1016\/j.micinf.2025.105563","DOI":"10.1016\/j.micinf.2025.105563"},{"key":"5394_CR24","doi-asserted-by":"publisher","first-page":"100910","DOI":"10.1016\/j.onehlt.2024.100910","volume":"19","author":"C Lv","year":"2024","unstructured":"Lv C, Leng J, Qian M, Sun B, Ye H, Li M, Zhou N, Cheng Z, Chen Y, Guo X, Shang J, Zhang L, Zhu Y (2024) Antimicrobial resistance in Escherichia coli and Staphylococcus aureus at human-animal interfaces on Chongming Island, shanghai: A one health perspective. One Health 19:100910. https:\/\/doi.org\/10.1016\/j.onehlt.2024.100910","journal-title":"One Health"},{"issue":"40","key":"5394_CR25","doi-asserted-by":"publisher","first-page":"2500196","DOI":"10.2807\/1560-7917.ES.2025.30.40.2500196","volume":"30","author":"H Ilmavirta","year":"2025","unstructured":"Ilmavirta H, Ollgren J, R\u00e4is\u00e4nen K, Kinnunen T, Jalava J, Lyytik\u00e4inen O (2025) Epidemiology and risk factors of Escherichia coli bloodstream infections associated with extended-spectrum beta-lactamase production: a National surveillance and data linkage study, Finland, 2018 to 2023. Euro Surveill 30(40):2500196. https:\/\/doi.org\/10.2807\/1560-7917.ES.2025.30.40.2500196","journal-title":"Euro Surveill"},{"issue":"5","key":"5394_CR26","doi-asserted-by":"publisher","first-page":"106762","DOI":"10.1016\/j.ijantimicag.2023.106762","volume":"61","author":"BE Frescas","year":"2023","unstructured":"Frescas BE, McCoy CM, Kirby J, Bowden R, Mercuro NJ (2023) Outcomes associated with empiric cefepime for bloodstream infections caused by ceftriaxone-resistant, cefepime-susceptible Escherichia coli and Klebsiella pneumoniae. Int J Antimicrob Agents 61(5):106762. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106762","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"5394_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3343\/alm.2021.41.5.455","volume":"41","author":"YJ Baek","year":"2021","unstructured":"Baek YJ, Kim YA, Kim D et al (2021) Risk factors for Extended-Spectrum-\u03b2-Lactamase-Producing Escherichia coli in Community-Onset bloodstream infection: impact on Long-Term care hospitals in Korea. Ann Lab Med 41(5):455\u2013462. https:\/\/doi.org\/10.3343\/alm.2021.41.5.455","journal-title":"Ann Lab Med"},{"issue":"10","key":"5394_CR28","doi-asserted-by":"publisher","first-page":"e0296123","DOI":"10.1128\/spectrum.02961-23","volume":"12","author":"C Lopera","year":"2024","unstructured":"Lopera C, Monz\u00f3 P, Aiello TF et al (2024) Prevalence and impact of multidrug-resistant bacteria in solid cancer patients with bloodstream infection: a 25-year trend analysis. Microbiol Spectr 12(10):e0296123. https:\/\/doi.org\/10.1128\/spectrum.02961-23","journal-title":"Microbiol Spectr"},{"issue":"6","key":"5394_CR29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.cmi.2021.12.009","volume":"28","author":"SF Feldman","year":"2022","unstructured":"Feldman SF, Temkin E, Wullfhart L et al (2022) A nationwide population-based study of Escherichia coli bloodstream infections: incidence, antimicrobial resistance and mortality. Clin Microbiol Infect 28(6):879. .e1-879.e7","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5394_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12866-023-03081-8","volume":"23","author":"M Roshani","year":"2023","unstructured":"Roshani M, Taheri M, Goodarzi A, Yosefimashouf R, Shokoohizadeh L (2023) Evaluation of antibiotic resistance, toxin-antitoxin systems, virulence factors, biofilm-forming strength and genetic linkage of Escherichia coli strains isolated from bloodstream infections of leukemia patients. BMC Microbiol 23(1):327. https:\/\/doi.org\/10.1186\/s12866-023-03081-8","journal-title":"BMC Microbiol"},{"issue":"7","key":"5394_CR31","doi-asserted-by":"publisher","first-page":"e0019923","DOI":"10.1128\/jcm.00199-23","volume":"61","author":"A Brumwell","year":"2023","unstructured":"Brumwell A, Sutton G, Lantos PM et al (2023) Escherichia coli ST131 associated with increased mortality in bloodstream infections from urinary tract source. J Clin Microbiol 61(7):e0019923. https:\/\/doi.org\/10.1128\/jcm.00199-23","journal-title":"J Clin Microbiol"},{"issue":"1","key":"5394_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/jac\/dkw402","volume":"72","author":"SE Battle","year":"2017","unstructured":"Battle SE, Bookstaver PB, Justo JA, Kohn J, Albrecht H, Al-Hasan MN (2017) Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother 72(1):299\u2013304. https:\/\/doi.org\/10.1093\/jac\/dkw402","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"5394_CR33","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/cid\/ciz319","volume":"70","author":"G Martinez-Nadal","year":"2020","unstructured":"Martinez-Nadal G, Puerta-Alcalde P, Gudiol C et al (2020) Inappropriate empirical antibiotic treatment in High-risk neutropenic patients with bacteremia in the era of multidrug resistance. Clin Infect Dis 70(6):1068\u20131074. https:\/\/doi.org\/10.1093\/cid\/ciz319","journal-title":"Clin Infect Dis"},{"issue":"8","key":"5394_CR34","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1093\/jac\/dkaa161","volume":"75","author":"V de Lastours","year":"2020","unstructured":"de Lastours V, Laou\u00e9nan C, Royer G et al (2020) Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it. J Antimicrob Chemother 75(8):2334\u20132343. https:\/\/doi.org\/10.1093\/jac\/dkaa161","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"5394_CR35","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3390\/microorganisms11051121","volume":"11","author":"JY Ahn","year":"2023","unstructured":"Ahn JY, Ahn SM, Kim JH, Jeong SJ, Ku NS, Choi JY, Yeom JS, Song JE (2023) Clinical characteristics and associated factors for mortality in patients with Carbapenem-Resistant Enterobacteriaceae bloodstream infection. Microorganisms 11(5):1121. https:\/\/doi.org\/10.3390\/microorganisms11051121","journal-title":"Microorganisms"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05394-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05394-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05394-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:34:09Z","timestamp":1776350049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05394-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["5394"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05394-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of Fujian Medical University Union Hospital approved this study and granted a waiver of individual consent (Approval No. 2023KY202).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}